RSV Prevention, Part IV: Immunocompromised Populations

Summary

Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.

Panelists

Moderator

Sarah Moselle , Associate Principal, Policy

Sarah Moselle supports clients with strategy development and implementation across a range of health policy and market access issues in US and international contexts.

Speaker

Haley Payne , Consultant I, Policy

Haley Payne provides subject matter expertise in vaccines, preventive services, pandemic preparedness and response, and healthcare quality to support clients' above-brand and brand-level policy objectives.